镓-68 PSMA PET/CT 偶然发现气管腺样囊性癌一例
一例66岁、活检证实前列腺腺癌且PSA 16 ng/mL的男性患者行68Ga-PSMA PET/CT分期,除前列腺原发灶局灶性摄取外,另见气管内息肉样管腔内病灶呈强烈PSMA表达,组织病理学证实为腺样囊性癌,提示该模态在前列腺癌之外也具有价值。
要点
- 68Ga-PSMA PET/CT除检出前列腺原发灶外,还偶然发现气管内PSMA高摄取病灶。
- 气管病灶经组织病理学证实为腺样囊性癌。
- PSMA在部分非前列腺肿瘤及正常组织中也可表达。
核心结论
- 68Ga-PSMA PET/CT在前列腺癌分期中偶然检出气管腺样囊性癌,提示该模态的应用价值不限于前列腺癌。
研究设计与样本
- 本文为单例病例报告:一例66岁、活检证实前列腺腺癌且PSA 16 ng/mL的男性患者接受68Ga-PSMA PET/CT分期。
主要发现
- 前列腺中部、以左侧为主见与前列腺原发恶性肿瘤一致的局灶性摄取。
- 气管内一息肉样管腔内病灶显示强烈PSMA表达,组织病理学证实为腺样囊性癌。
临床怎么用
- 阅读68Ga-PSMA PET/CT时应注意前列腺外器官的异常PSMA摄取,气管局灶性高摄取需考虑非前列腺肿瘤可能。
局限性
- 本文为单例病例报告,未报告诊断效能、随访或对照数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PSMA PET, widely used in prostate cancer, targets a transmembrane glycoprotein overexpressed in tumor cells, and PSMA expression is also seen in some nonprostatic tumors and normal tissues. In this case, a 66-year-old man with biopsy-proven prostate adenocarcinoma and PSA 16 ng/mL underwent 68 Ga-PSMA PET/CT for staging. Focal uptake consistent with primary prostate malignancy was detected in the mid-prostate, predominantly left lateral. In addition, a polypoid intraluminal tracheal lesion demonstrated intense PSMA expression. Histopathology confirmed adenoid cystic carcinoma, emphasizing the modality's value beyond prostate cancer.
引用
- Sabuncu S, Karyağar S, Seyhan EC, et al. A Case of Incidental Adenoid Cystic Carcinoma of the Trachea on Gallium-68 PSMA PET/CT Imaging. Clin Nucl Med. 2026. PMID: 41954949. doi:10.1097/RLU.0000000000006458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。